This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Ipratropium bromide

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Ipratropium is an antimuscarinic bronchodilator used in the treatment of reversible airways obstruction, and particularly in chronic bronchitis.

It differs from the á2 adrenoceptor stimulators by virtue of a slower onset of action but has a longer action, and good maintenance of bronchodilation can be achieved with about three aerosol administrations per day.

Ipratropium bromide is used in the treatment of chronic bronchitis and in asthma, especially in the elderly, in whom salbutamol is less effective.

In asthma it reverses bronchoconstriction, with an onset of action of 30 to 45 minutes; thus it is not helpful in an acute attack.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.